Minu Dutia

1.1k citations

21 papers · 908 indexed · h-index 14

Co-authors: Jonathan D. Bloom Elwood Largis Allan Wissner Dennis Powell Michael Burns Thomas H. Claus Frank Boschelli Diane H. Boschelli
Topics: Synthesis and biological activity (7 papers)Melanoma and MAPK Pathways (7 papers)Protein Kinase Regulation and GTPase Signaling (7 papers)
Cited by: Organic Chemistry Hematology Toxicology
Journals: Blood Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Canada

In The Last Decade

Minu Dutia

21 papers receiving 859 citations

Peers

Countries citing papers authored by Minu Dutia

Since Specialization

Citations

This map shows the geographic impact of Minu Dutia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minu Dutia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minu Dutia more than expected).

Fields of papers citing papers by Minu Dutia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minu Dutia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minu Dutia. The network helps show where Minu Dutia may publish in the future.

Co-authorship network of co-authors of Minu Dutia

This figure shows the co-authorship network connecting the top 25 collaborators of Minu Dutia. A scholar is included among the top collaborators of Minu Dutia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minu Dutia. Minu Dutia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibitors with in Vivo Activity 2010 ·Journal of Medicinal Chemistry ·Xiaolun Wang,Dan M. Berger,Edward J. Salaski,(unknown),Minu Dutia,(unknown),Yongbo Hu,Jeremy I. Levin,Dennis Powell,Donald Wojciechowicz,Karen Collins,(unknown),Judy Lucas	14
2	Novel pyrazolopyrimidines as highly potent B-Raf inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Martin J. Di Grandi,Dan M. Berger,Darrin W. Hopper,Chunchun Zhang,Minu Dutia,(unknown),(unknown),Jeremy I. Levin,George Diamantidis,Christoph W. Zapf,Jonathan D. Bloom,Yongbo Hu,Dennis Powell,Donald Wojciechowicz,Karen Collins,(unknown)	27
3	Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Dan M. Berger,(unknown),Minu Dutia,Dennis Powell,(unknown),Ariamala Gopalsamy,Jeremy I. Levin,Kyung‐Hee Kim,Weixin Xu,James E. Wilhelm,Yongbo Hu,Karen Collins,Larry Feldberg,(unknown),(unknown),Donald Wojciechowicz,Robert Mallon	32
4	4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry ·Dan M. Berger,Minu Dutia,Dennis Powell,(unknown),(unknown),Robert Mallon,Donald Wojciechowicz,(unknown),Larry Feldberg,Karen Collins,Indrasish Ray Chaudhuri	16
5	Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Scott C. Mayer,Dan M. Berger,Diane H. Boschelli,Frank Boschelli,Li Di,Xuemei Du,Minu Dutia,(unknown),Mark Johnson,Cynthia Hess Kenny,Girija Krishnamurthy,F. Moy,Susan Petusky,Diane Tkach,(unknown),Biqi Wu,Weixin Xu	34
6	Synthesis of 7-(E)-alkenyl-4-amino-3-quinolinecarbonitriles via Pd-mediated Heck, Stille, and Suzuki reactions 2008 ·Tetrahedron ·Yanong D. Wang,Minu Dutia,M. Brawner Floyd,Amar S. Prashad,Dan Berger,Melissa Lin	11
7	Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors 2007 ·Tetrahedron Letters ·Darrin W. Hopper,Minu Dutia,Dan M. Berger,Dennis Powell	7
8	Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade 2003 ·Bioorganic & Medicinal Chemistry Letters ·Dan Berger,Minu Dutia,Dennis Powell,Biqi Wu,Allan Wissner,Diane H. Boschelli,M. Brawner Floyd,Nan Zhang,(unknown),Jeremy I. Levin,Xuemei Du,Donald Wojciechowicz,Carolyn Discafani,Constance Kohler,Steven C. Kim,Larry Feldberg,Karen Collins,Robert Mallon	25
9	Regioselective Synthesis ofa Potent Src Kinase Inhibitor: 4-(2,4-Dichloro-5-methoxyphenylamino)-7-methoxy-8-(2-morpholin-4-ylethoxy)benzo[g]quinoline-3-carbonitrile 2003 ·Synthesis ·Dan Berger,Gary H. Birnberg,(unknown),Minu Dutia,Dennis Powell,(unknown)	4
10	Novel Tyrosine Kinase Inhibitors Suppress BCR-ABL Signaling and Induce Apoptosis in STI-571 Sensitive and Resistant CML Cells 2002 ·Blood ·(unknown),(unknown),Moshe Talpaz,Minu Dutia,(unknown),Diane H. Boschelli,Frank Boschelli	4
11	8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src Kinase Inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Dan Berger,Minu Dutia,Dennis Powell,Biqi Wu,Allan Wissner,(unknown),Jennifer M. Weber,Frank Boschelli	8
12	Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Dan Berger,Minu Dutia,Dennis Powell,Allan Wissner,(unknown),(unknown),Jennifer M. Weber,Frank Boschelli	18
13	Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles 2001 ·Journal of Medicinal Chemistry ·Diane H. Boschelli,Yanong D. Wang,Fei Ye,Biqi Wu,Nan Zhang,Minu Dutia,Dennis Powell,Allan Wissner,Kim Arndt,Jennifer M. Weber,Frank Boschelli	72
14	Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase Activity 2001 ·Journal of Medicinal Chemistry ·Diane H. Boschelli,Fei Ye,Yanong D. Wang,Minu Dutia,Steve Johnson,Biqi Wu,Karen Miller,Dennis Powell,(unknown),Mairead Young,Mark Tischler,Kim Arndt,Carolyn Discafani,(unknown),Jay Gibbons,(unknown),Judy Lucas,Jennifer M. Weber,Frank Boschelli	179
15	Novel Multidrug Resistance Reversal Agents 1999 ·Journal of Medicinal Chemistry ·Dan Berger,(unknown),Minu Dutia,Lee M. Greenberger,William Hallett,Rolf Paul,Dennis Powell	60
16	Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),(unknown),Michael Burns,(unknown),Claire M. Fraser,(unknown),A. Donny Strosberg,Elwood Largis,Minu Dutia,Jonathan D. Bloom	72
17	Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent 1992 ·Journal of Medicinal Chemistry ·Jonathan D. Bloom,Minu Dutia,(unknown),Allan Wissner,Michael Burns,Elwood Largis,(unknown),Thomas H. Claus	252
18	Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogs 1989 ·Journal of Medicinal Chemistry ·(unknown),Jonathan D. Bloom,Minu Dutia,Andrew S. Katocs,Elwood Largis	24
19	Potential antiatherosclerotic agents. 5. An acyl-coenzyme A:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity 1986 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Elwood Largis,Minu Dutia,(unknown),Jonathan D. Bloom,Andrew S. Katocs	33
20	ChemInform Abstract: Potential Antiatherosclerotic Agents. Part 5. An Acyl‐CoA: Cholesterol O‐Acyltransferase Inhibitor with Hypocholesterolemic Activity. 1986 ·Chemischer Informationsdienst ·(unknown),(unknown),Elwood Largis,Minu Dutia,(unknown),Jonathan D. Bloom,Andrew S. Katocs	3

About Minu Dutia

Minu Dutia is a scholar working on Toxicology, Organic Chemistry and Clinical Biochemistry, having authored 21 papers that have together received 908 indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Melanoma and MAPK Pathways (7 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). The work is most often cited by research in Organic Chemistry (336 citations), Hematology (99 citations) and Toxicology (26 citations). Minu Dutia has collaborated with scholars based in United States and Canada. Frequent co-authors include Jonathan D. Bloom, Elwood Largis, Allan Wissner, Dennis Powell, Michael Burns, Thomas H. Claus, Frank Boschelli, Diane H. Boschelli, Biqi Wu and Jennifer M. Weber. Their work appears in journals such as Blood, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact